Madison Square Garden Sports (MSGS) director awarded 727 RSUs in stock plan
Rhea-AI Filing Summary
Madison Square Garden Sports Corp. director Ivan G. Seidenberg reported an equity award in the form of restricted stock units. On 12/08/2025, he received 727 restricted stock units (RSUs) under the company’s 2015 Stock Plan for Non-Employee Directors. Each RSU represents the right to receive one share of Class A common stock or the cash equivalent.
The RSUs are fully vested on the grant date and will be settled in stock or cash on the first business day 90 days after Mr. Seidenberg’s separation from service. After this grant, he beneficially owns 7,520 derivative securities, held directly.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Madison Square Garden Sports Corp. (MSGS) report?
Madison Square Garden Sports Corp. reported that director Ivan G. Seidenberg received an equity award of 727 restricted stock units (RSUs) on 12/08/2025 under the company’s 2015 Stock Plan for Non-Employee Directors.
What does each RSU granted to the MSGS director represent?
Each RSU granted to the director represents a right to receive one share of Class A Common Stock of Madison Square Garden Sports Corp. or the cash equivalent of that share.
When do the RSUs granted to the MSGS director vest and settle?
The RSUs are fully vested on the date of grant and will be settled in stock or cash on the first business day 90 days after separation from service of the director.
How many derivative securities does the MSGS director own after the reported transaction?
Following the reported RSU grant, the director beneficially owns 7,520 derivative securities of Madison Square Garden Sports Corp., held directly.
Under what plan were the RSUs for the MSGS director granted?
The 727 RSUs were granted under the Madison Square Garden Sports Corp. 2015 Stock Plan for Non-Employee Directors, as amended.
What is the exercise or purchase price for the RSUs reported by MSGS?
The RSUs have an exercise price of $0, reflecting that they are stock-based awards granted as director compensation rather than options requiring a purchase price.